Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Legere Pharmaceuticals is a specialty pharmaceutical and nutraceutical company that focuses on weight loss, hormone replacement therapy, and nutritional wellness. Established in 1973, the company provides healthcare professionals with a comprehensive range of FDA-approved medications and high-quality dietary supplements. Legere is particularly well-known for its support of bariatric clinics and medical weight loss programs through both its branded products and private labeling services. Their portfolio includes sympathomimetic amines for appetite suppression, injectable vitamins, and specialized metabolic support formulas. The company operates out of Scottsdale, Arizona, serving a national network of physicians and wellness centers. By combining pharmacological treatments with nutritional support, Legere offers a holistic approach to metabolic health and patient management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Legere Pharmaceuticals.